BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 22049184)

  • 1. Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy.
    Saner FH; Treckmann JW; Geis A; Lösch C; Witzke O; Canbay A; Herget-Rosenthal S; Kribben A; Paul A; Feldkamp T
    Nephrol Dial Transplant; 2012 Apr; 27(4):1651-7. PubMed ID: 22049184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate anticoagulation in critically ill patients with liver and kidney failure.
    Balogun RA; Turgut F; Caldwell S; Abdel-Rahman EM
    J Nephrol; 2012; 25(1):113-9. PubMed ID: 21607918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience.
    Pertica N; Cicciarella L; Carraro A; Montin U; Violi P; Lupo A; Zaza G
    Transplant Proc; 2017 May; 49(4):674-676. PubMed ID: 28457369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional citrate anticoagulation for continuous renal replacement therapy in severe burns-a retrospective analysis of a protocol-guided approach.
    Gille J; Sablotzki A; Malcharek M; Raff T; Mogk M; Parentin T
    Burns; 2014 Dec; 40(8):1593-601. PubMed ID: 24612996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
    Stucker F; Ponte B; Tataw J; Martin PY; Wozniak H; Pugin J; Saudan P
    Crit Care; 2015 Mar; 19(1):91. PubMed ID: 25881975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regional citrate anticoagulation for continuous haemodiafiltration in the postoperative period].
    Kucewicz E; Zegleń S; Wojarski J; Ochman M; Skuza K; Szczepańska A; Podwińska E; Pacholewicz J; Przybylski R
    Anestezjol Intens Ter; 2009; 41(4):238-41. PubMed ID: 20201346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
    Wu MY; Hsu YH; Bai CH; Lin YF; Wu CH; Tam KW
    Am J Kidney Dis; 2012 Jun; 59(6):810-8. PubMed ID: 22226564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
    Oudemans-van Straaten HM
    Blood Purif; 2010; 29(2):191-6. PubMed ID: 20093826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and efficacy of regional citrate anticoagulation in continuous renal replacement therapy in the presence of acute kidney injury after hepatectomy].
    Zhang C; Lin T; Zhang J; Liang H; Di Y; Li N; Gao J; Wang W; Liu S; Wang Z; Jiang H; Liu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Aug; 30(8):777-782. PubMed ID: 30220281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction.
    De Vico P; Messino V; Tartaglione A; Beccaris C; Buonomo C; Talarico D; Prati P; Sabato AF; Colella DF
    Ther Apher Dial; 2015 Jun; 19(3):272-8. PubMed ID: 25656632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis.
    Morgera S; Haase M; Ruckert M; Krieg H; Kastrup M; Krausch D; Vargas-Hein O; Zuckermann-Becker H; Peters H; Pohlmeier R; Neumayer HH
    Nephron Clin Pract; 2005; 101(4):c211-9. PubMed ID: 16155399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy for Acute Kidney Injury Patients with Acute Liver Dysfunction: a Retrospective Observational Study.
    Yu Y; Peng S; Cen Z; Cai J; Wang W; Tang Y; Du M; Liu Z; Chang P
    Kidney Blood Press Res; 2018; 43(4):1065-1074. PubMed ID: 29969768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in continuous renal replacement therapy: citrate anticoagulation update.
    Tolwani A; Wille KM
    Blood Purif; 2012; 34(2):88-93. PubMed ID: 23095407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different?
    Agarwal B; Shaw S; Shankar Hari M; Burroughs AK; Davenport A
    J Hepatol; 2009 Sep; 51(3):504-9. PubMed ID: 19615775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nafamostat mesylate in continuous renal replacement therapy among patients at high risk of bleeding.
    Baek NN; Jang HR; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    Ren Fail; 2012; 34(3):279-85. PubMed ID: 22251267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.